2 results
Approved WMOCompleted
Primary: Antiviral efficacy of dolutagravir in combination with Kivexa (abacavir en lamivudine) after 48 weeks of treatment in comparison with Atripla (tenofovir, emtricitabine and efavirenz). Secondary: Antiviral efficacy after 96 and 144 weeks,…
Approved WMOCompleted
the primary objective is to investigate the feasibility of the use of SNS as a potential treatment for distal colitis in patients with inflammatory bowel disease. Secondary Objective(s): - whether there is a beneficial effect of sacral…